BHOWMICK NEIL (Chief Scientific Officer) received a stock award from KAIROS PHARMA, LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/30/2025ACC: 0001493152-25-029601
Officer· Chief Scientific Officer
Since Sep 2024
+171.76K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
171.76K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+171.76K
Price / share
—
Trade value
—
% of position
15.1%
10/8/2025
1.14M→1.31M
Total
Net shares
+171.76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 10/8/2025 | A · Award | +171.76K | — | — | 15.1% | 1.14M | 1.31M |
| Total | +171.76K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported